Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (191-200 of 266) with videos related to

Pageof 27
Sort By:
Cancer Immunology Research|October 4, 2017
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor MicroenvironmentYuki Muroyama, Thomas R Nirschl, Christina M Kochel, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Plos One|July 12, 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma modelZineb Belcaid, Jillian A Phallen, Jing Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical OutcomeDebraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Cancer Cell|May 15, 2014
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasiaFlorencia McAllister, Jennifer M Bailey, Janivette Alsina, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 18, 2009
Tc17 CD8 T cells: functional plasticity and subset diversityHung-Rong Yen, Timothy J Harris, Satoshi Wada, et al.
Nature Medicine|January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Kobe C Yuen, Silke Gillessen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasJing Zeng, Alfred P See, Jillian Phallen, et al.
Pageof 27

Showing results (191-200 of 266) with videos related to

Sort By:
Pageof 27
Cancer Immunology Research|October 4, 2017
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor MicroenvironmentYuki Muroyama, Thomas R Nirschl, Christina M Kochel, et al.
Journal for Immunotherapy of Cancer|July 1, 2021
TGM4: an immunogenic prostate-restricted antigenZoila A Lopez-Bujanda, Aleksandar Obradovic, Thomas R Nirschl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 31, 2015
Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention TrialTeemu J Murtola, Bora Gurel, Martin Umbehr, et al.
Plos One|July 12, 2014
Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma modelZineb Belcaid, Jillian A Phallen, Jing Zeng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2015
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical OutcomeDebraj GuhaThakurta, Nadeem A Sheikh, Li-Qun Fan, et al.
Cancer Cell|May 15, 2014
Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasiaFlorencia McAllister, Jennifer M Bailey, Janivette Alsina, et al.
International Journal of Cancer|September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastomaSarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 18, 2009
Tc17 CD8 T cells: functional plasticity and subset diversityHung-Rong Yen, Timothy J Harris, Satoshi Wada, et al.
Nature Medicine|January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Kobe C Yuen, Silke Gillessen, et al.
International Journal of Radiation Oncology, Biology, Physics|March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomasJing Zeng, Alfred P See, Jillian Phallen, et al.
Pageof 27